MARKET

LBRX

LBRX

LB Pharmaceuticals
NASDAQ
19.82
-0.04
-0.20%
After Hours: 19.82 0 0.00% 17:35 12/16 EST
OPEN
19.79
PREV CLOSE
19.86
HIGH
20.13
LOW
19.03
VOLUME
457.59K
TURNOVER
--
52 WEEK HIGH
23.15
52 WEEK LOW
13.36
MARKET CAP
398.38M
P/E (TTM)
-140.9673
1D
5D
1M
3M
1Y
5Y
1D
LB Pharmaceuticals management to meet with Piper Sandler
TipRanks · 14h ago
Weekly Report: what happened at LBRX last week (1208-1212)?
Weekly Report · 1d ago
LB Pharmaceuticals Price Target Raised to $35.00/Share From $27.00 by Stifel
Dow Jones · 5d ago
LB Pharmaceuticals Is Maintained at Buy by Stifel
Dow Jones · 5d ago
Stifel Maintains Buy on LB Pharmaceuticals, Raises Price Target to $35
Benzinga · 5d ago
Stifel Nicolaus Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)
TipRanks · 5d ago
LB Pharmaceuticals price target raised to $35 from $27 at Stifel
TipRanks · 5d ago
U.S. RESEARCH ROUNDUP-BioNTtech, GE Vernova, Synopsys
Reuters · 5d ago
More
About LBRX
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a Phase III-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The Company is also developing a long-acting injectable, or LAI, formulation of LB-102, which improves compliance, a common issue in patients with schizophrenia and bipolar disorder.

Webull offers LB Pharmaceuticals Inc stock information, including NASDAQ: LBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LBRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LBRX stock methods without spending real money on the virtual paper trading platform.